
Laurie Sehn
Chair of the Lymphoma Tumor Group at BC Cancer in Vancouver, Canada, and a podcast editor at Blood.
Best podcasts with Laurie Sehn
Ranked by the Snipd community

Nov 17, 2023 • 16min
iwNHL 2023 Session III: Recent updates with the use of antibody-drug conjugates in NHL
John Gribben and Laurie Sehn discuss the use of antibody-drug conjugates (ADCs) in NHL. They explore challenges in comparing treatment options, modulation of target antigen, and FDA's changing requirements for drug approval. Recent updates in the use of ADCs, including decreased accelerated approvals and the importance of efficacy and safety, are also highlighted.

Dec 16, 2022 • 12min
iwNHL Session V: novel therapies in NHL – the role of ADCs
Laurie Sehn and Carmelo Carlo Stella discuss novel therapies in NHL, focusing on antibody-drug conjugates (ADCs). They talk about the updates on ADCs like brentuximab vedotin, loncastuximab tesirine, and more, and their place in the treatment landscape. Topics include the promising results of Bratuxima of Badoten, comparing a novel therapy with standard treatment, exploring a promising ADC for lymphomas, and the efficacy of pulatuzumab in diffuse large bicell lymphoma treatment.